C. Mahaffey

Anti-CD 22 Monoclonal Antibody Enhances Bortezomib-mediated Lymphomacidal Activity in a Sequence Dependent Manner Permalink

Donnell, H. McKnight, J. Tuscano, 2012 .

The HB22.7 Anti-CD22 monoclonal antibody enhances bortezomib-mediated lymphomacidal activity in a sequence dependent manner

R. O’Donnell, H. McKnight, J. Tuscano, 2011, Journal of hematology & oncology.

Schedule-dependent apoptosis in K-ras mutant non-small-cell lung cancer cell lines treated with docetaxel and erlotinib: rationale for pharmacodynamic separation.

D. Gandara, P. Gumerlock, P. Mack, 2007, Clinical lung cancer.

Multidrug-resistant protein-3 gene regulation by the transcription factor Nrf2 in human bronchial epithelial and non-small-cell lung carcinoma.

Hongqiao Zhang, H. Forman, P. Mack, 2009, Free radical biology & medicine.

Impact of AKT inhibitor MK-2206 on erlotinib resistance in non-small cell lung cancer (NSCLC).

D. Gandara, P. Mack, P. Lara, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Multidrug resistant protein-three gene regulation

C. Mahaffey, 2010 .

Dual Blockade of PKA and NF–κB Inhibits H2 Relaxin-Mediated Castrate-Resistant Growth of Prostate Cancer Sublines and Induces Apoptosis

C. Tepper, R. Gandour-Edwards, P. Ghosh, 2011, Hormones & cancer.

Aberrant Regulation of the MRP3 Gene in Non-small Cell Lung Carcinoma

D. Gandara, Hongqiao Zhang, H. Forman, 2012, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Apoptotic effects of the docetaxel->OSI-774 combination in non-small cell lung carcinoma (NSCLC) cells

D. Gandara, P. Gumerlock, P. Mack, 2004 .

Multidrug-resistant protein-3 gene regulation by the transcription factor Nrf2 in human bronchial epithelial and non-small-cell lung carcinoma.

Hongqiao Zhang, H. Forman, P. Mack, 2009, Free radical biology & medicine.